COVID-19
Photo provided by the National Institute of Allergy and Infectious Diseases’s Rocky Mountain Laboratories.

CORONAVIRUS RESEARCH GUIDANCE

The University of Colorado Denver | Anschutz Medical Campus continues to closely monitor the outbreak of coronavirus disease, known as COVID-19. With the ongoing concern about the spread of this disease, and recent extension of federal and local guidance, the CU Anschutz Medical Campus has extended remote working through Thursday, April 30, and all employees at CU Denver whose presence is not designated as critical are to work remotely until further notice.

As there are different considerations for bench, animal and clinical research, each research team or laboratory is best positioned to create a continuity plan that will meet their unique needs. The guidance below is provided to facilitate the development of that plan. Please remember that unit Continuity of Operations Plans (COOPs) are also required to be completed, which will help with this process. Please contact michael.bear@cuanschutz.edu with questions.

MOST RECENT UPDATES

  • Additional Research Access Information
    March 23, 2020
    First, we want to thank everyone in the research community for your flexibility and partnership in working through the changes of the last few days...

Previous Updates

FREQUENTLY ASKED QUESTIONS FOR SPONSORED PROJECT ADMINISTRATION

NEXT STEPS

The university is following guidance from the Colorado Department of Public Health & Environment (CDPHE), CDC and other agencies. The individuals involved in planning the university’s response are working in consultation with experts from UCHealth, EHS (Environmental Health and Safety), University Emergency Management, the School of Medicine and others on campus to update the university’s existing pandemic response plan in the event of widespread U.S. community transmission of COVID-19 or announcement of a COVID-19 pandemic. Expect to see additional updates, including research specific FAQs via email, as well as updates to the university’s COVID-19 webpages.